S&P 500   2,987.55 (-0.27%)
DOW   26,965.56 (-0.22%)
QQQ   192.63 (-0.46%)
AAPL   234.38 (-0.40%)
FB   187.81 (-0.57%)
AMZN   1,778.44 (+0.63%)
CGC   19.34 (-3.78%)
NVDA   197.08 (+0.36%)
MU   46.25 (-0.43%)
BABA   175.02 (-0.15%)
GE   9.00 (+1.12%)
TSLA   259.01 (+0.43%)
AMD   30.89 (+0.55%)
T   37.96 (+0.16%)
F   9.15 (+0.77%)
ACB   3.64 (-3.20%)
NFLX   283.67 (-0.20%)
BAC   30.26 (+1.78%)
GILD   65.54 (+0.37%)
DIS   130.02 (+0.20%)
S&P 500   2,987.55 (-0.27%)
DOW   26,965.56 (-0.22%)
QQQ   192.63 (-0.46%)
AAPL   234.38 (-0.40%)
FB   187.81 (-0.57%)
AMZN   1,778.44 (+0.63%)
CGC   19.34 (-3.78%)
NVDA   197.08 (+0.36%)
MU   46.25 (-0.43%)
BABA   175.02 (-0.15%)
GE   9.00 (+1.12%)
TSLA   259.01 (+0.43%)
AMD   30.89 (+0.55%)
T   37.96 (+0.16%)
F   9.15 (+0.77%)
ACB   3.64 (-3.20%)
NFLX   283.67 (-0.20%)
BAC   30.26 (+1.78%)
GILD   65.54 (+0.37%)
DIS   130.02 (+0.20%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Elanco Animal HealthAlnylam PharmaceuticalsOno PharmaceuticalArray BiopharmaMylan
SymbolNYSE:ELANNASDAQ:ALNYOTCMKTS:OPHLFN/ANASDAQ:MYL
Price Information
Current Price$27.36$80.85$17.92N/A$18.88
52 Week RangeHoldBuyN/AHoldBuy
Analyst Ratings
Consensus RecommendationHoldBuyN/AHoldBuy
Consensus Price Target$33.09$112.75N/A$38.47$29.82
% Upside from Price Target20.94% upside39.46% upsideN/A∞ upside57.92% upside
Trade Information
Market Cap$9.91 billion$8.99 billion$9.21 billion$10.68 billion$9.75 billion
BetaN/A2.40.881.71.8
Average Volume4,117,611660,2831,0904,985,5775,070,051
Sales & Book Value
Annual Revenue$3.07 billion$74.91 million$2.60 billion$173.77 million$11.43 billion
Price / Sales3.26120.023.540.000.85
Cashflow$2.03 per shareN/A$1.03 per shareN/A$8.66 per share
Price / Cash13.51N/A17.34N/A2.18
Book Value$14.22 per share$12.87 per share$9.20 per share$1.04 per share$23.60 per share
Price / Book1.926.281.950.000.80
Profitability
Net Income$86.50 million$-761,490,000.00$464.98 million$-147,340,000.00$352.50 million
EPS$1.18($7.57)$0.90($0.73)$4.58
Trailing P/E Ratio22.97N/A19.91N/A4.12
Forward P/E Ratio21.89N/A15.86N/A4.22
P/E GrowthN/AN/AN/AN/A$0.90
Net Margins4.69%-848.70%17.90%-52.64%0.30%
Return on Equity (ROE)7.83%-56.42%9.25%-48.51%18.93%
Return on Assets (ROA)4.55%-43.01%8.17%-24.15%7.00%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.45%0.17%N/A0.45%1.15%
Current Ratio3.07%6.28%N/A5.70%1.37%
Quick Ratio1.71%6.16%N/A5.65%0.77%
Ownership Information
Institutional Ownership PercentageN/A94.27%N/AN/A84.77%
Insider Ownership Percentage0.04%3.60%N/A2.10%0.82%
Miscellaneous
Employees5,5901,0653,48029835,000
Shares Outstanding365.71 million111.21 million514.12 million223.13 million515.87 million
Next Earnings Date11/5/2019 (Estimated)11/6/2019 (Estimated)11/7/2019 (Estimated)10/28/2019 (Estimated)11/4/2019 (Estimated)
OptionableOptionableOptionableNot OptionableOptionableOptionable
 Elanco Animal HealthAlnylam PharmaceuticalsOno PharmaceuticalArray BiopharmaMylan

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel